acetyl-l-carnitine tmao effect on heart Frontiers A Multi-omic Association Study of

doi:10.1080/13697137.2021.1965115

Multiple gene therapy strategies utilizing patients own stem cells, are also being pursued, but this has the disadvantage of myeloablative conditioning (Leonard et al., 2020)

Multiple animal studies including post-infarction models show Thymosin Beta-4 reduces scar tissue formation, promotes cardiomyocyte survival, and supports microvascular regeneration in damaged heart tissue.22 A 2010 study published in Annals of the New York Academy of Sciences showed that Thymosin Beta-4 initiated adult cardiac progenitor cell differentiation and cardiac repair in injured myocardium.23 While direct long COVID RCT data doesn't yet exist for TB-500, the mechanistic overlap with long COVID cardiovascular pathology is strong

Our medical team has extensive experience in providing this treatment and follows strict protocols to ensure your safety and comfort throughout the process